España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lexaria Bioscience
LEXX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.16
-0.04
-1.82%
At close: -
$2.12
-0.04
-1.83%
After Hours: 8:32 AM EDT
Get Report
Comment
Lexaria Bioscience (LEXX) Forecast
News
Earnings
Lexaria Bioscience (LEXX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lexaria Bioscience (NASDAQ:LEXX) Stock
Lexaria Bioscience Stock (NASDAQ: LEXX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Lexaria Bioscience Received Final 12-week Bod...
Benzinga Newsdesk
Thursday, November 14, 2024
Lexaria Signs Contract For New DehydraTECH GL...
Benzinga Newsdesk
Wednesday, November 13, 2024
Lexaria Bioscience Receives Human Research Et...
Benzinga Newsdesk
Tuesday, October 22, 2024
Lexaria Bioscience Announces That It Has Rece...
Benzinga Newsdesk
Tuesday, October 15, 2024
Lexaria Announces $5M Registered Direct Offer...
Benzinga Newsdesk
Wednesday, October 09, 2024
Lexaria Announces Dosing Bas Begun In Its GLP...
Benzinga Newsdesk
Tuesday, October 01, 2024
Lexaria Appoints Michael Shankman As Chief Fi...
Benzinga Newsdesk
Friday, September 27, 2024
Lexaria Receives Independent Review Board App...
Benzinga Newsdesk
Monday, September 23, 2024
Lexaria Bioscience 13D/Amended Filing Shows W...
Benzinga Newsdesk
Monday, September 02, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, August 29, 2024
Lexaria Bioscience Announces Tolerability And...
Benzinga Newsdesk
Tuesday, August 27, 2024
Lexaria Bioscience Announces Initial Results ...
Benzinga Newsdesk
Monday, August 19, 2024
Lexaria Bioscience Announces Results From Res...
Benzinga Newsdesk
Thursday, July 18, 2024
HC Wainwright & Co. Reiterates Buy on Lexaria...
Benzinga Newsdesk
Wednesday, July 17, 2024
Interim Body Weight Results From Lexaria's Di...
Benzinga Newsdesk
Tuesday, July 16, 2024
Lexaria Preparing For Strategic Growth, Expan...
Benzinga Newsdesk
Friday, July 12, 2024
Lexaria Bioscience Q3 EPS $(0.13) Misses $(0....
Benzinga Newsdesk
Wednesday, July 10, 2024
HC Wainwright & Co. Initiates Coverage On Lex...
Benzinga Newsdesk
Monday, July 08, 2024
Lexaria Receives 3 New Patents For Antiviral ...
Benzinga Newsdesk
Tuesday, June 18, 2024
Lexaria Bioscience Hires CRO To Oversee 12-We...
Benzinga Newsdesk
Wednesday, June 05, 2024
Lexaria Bioscience Announces Progress In Huma...
Benzinga Newsdesk
Tuesday, June 04, 2024
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, May 30, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Thursday, May 23, 2024
Lexaria Awards Contract To A CRO To Perform T...
Benzinga Newsdesk
Tuesday, May 21, 2024
Lexaria Granted Patent #21: Compositions and ...
Benzinga Newsdesk
Friday, May 17, 2024
Lexaria Bioscience shares are trading higher ...
Benzinga Newsdesk
Lexaria Bioscience Begins Dosing In GLP-1 Ani...
Benzinga Newsdesk
Monday, May 06, 2024
Lexaria Announces New Research Program To Eva...
Benzinga Newsdesk
Tuesday, April 30, 2024
Lexaria To Receive $4.7M Gross Proceeds In Wa...
Benzinga Newsdesk
Tuesday, April 16, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Lexaria Receives Ethics Review Board Approval...
Benzinga Newsdesk
Thursday, March 14, 2024
Lexaria Appoints Nelson Cabatuan As Chief Fin...
Benzinga Newsdesk
Tuesday, March 12, 2024
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, March 07, 2024
Lexaria Bioscience Hires Contract Research Or...
Benzinga Newsdesk
Tuesday, March 05, 2024
Maxim Group Maintains Buy on Lexaria Bioscien...
Benzinga Newsdesk
Watching Lexaria Bioscience; Traders Circulat...
Benzinga Newsdesk
Lexaria To Begin Diabetes And Weight Loss Ani...
Benzinga Newsdesk
Friday, March 01, 2024
Lexaria Announces FDA Clearance For Its Plann...
Benzinga Newsdesk
Wednesday, February 28, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, February 27, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Thursday, February 15, 2024
Why Lexaria Bioscience (LEXX) Shares Are Moving
Henry Khederian
Lexaria Bioscience Announces $3.6M Registered...
Benzinga Newsdesk
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Tuesday, January 30, 2024
Lexaria's Submits Investigational New Drug Ap...
Benzinga Newsdesk
Tuesday, January 16, 2024
Lexaria Bioscience Unveils Planned 2024 GLP-1...
Benzinga Newsdesk
Thursday, January 11, 2024
Lexaria Bioscience Corp. Proprietary Drug-Del...
Benzinga Newsdesk
Tuesday, January 09, 2024
Lexaria Bioscience Corp. Improves Delivery, E...
Benzinga Newsdesk
Thursday, January 04, 2024
Lexaria's Patented Technology Improved The Or...
Benzinga Newsdesk
Thursday, December 07, 2023
Lexaria Bioscience Corp. Announces That The C...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
